A simulated, randomized study on the safety and immunogenicity of three consecutive commercial-scale batches of the CTN-1V strain human rabies vaccine to verify the inter-batch consistency

• Autors principals: Lei Zhou (Autor), Jingjing Liu (Autor), Jia Li (Autor), Xuecheng Liu (Autor), Jingwu Zhang (Autor), Fei Nie (Autor), Jianmin Chen (Autor), Jing Chai (Autor), Jinchao Lv (Autor), Minghui Wang (Autor), Jiajie Yu (Autor), Wenjie Wu (Autor), Yuhua Li (Autor), Yuhui Zhang (Autor)
• Format: Llibre
• Publicat: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

In this study, we sought to evaluate the inter-batch consistency and safety of the CTN-1 V human rabies vaccine (Vero cells). A total of 594 healthy participants aged 10-60 years were enrolled from Mianzhu, Sichuan Province, and randomized into three batch groups to receive vaccination via the Essen...